Parameter | value |
---|---|
Subject number | 164 |
Age (years) | 53 ± 15 |
Males | 115(70) |
BMI, kg/m2 | 24.7 ± 4.1 |
LVEF, % | 54.2 ± 7.4 |
HbA1c (%) | 5.1 ± 1.0 |
Glycated albumin (%) | 12.8 ± 4.6 |
Oral beta-blocker therapy(n,%) | 135(82.3) |
Risk factors (n,%) | |
Hyperlipidemia | 61(37.2) |
Hypertension | 65(39.6) |
Current smoking | 76(46.3) |
Family history | 21(13) |
Obesity | 35(21) |
CGMS parameters | |
MBG(mmol/l) | 6.6 ± 0.8 |
MAGE (mmol/l) | 2.8 ± 1.6 |
SDBG(mmol/l) | 1.4 ± 0.5 |
The number of Mean episodes of hypoglycemia per patient | 1.7 ± 1.8 |
The numberof Mean episodes of hyperglycemia per patient | 2.4 ± 2.7 |
Mean duration of hypoglycemia per patient (h) | 1.6 ± 3.0 |
Mean duration of hyperglycemia per patient (h) | 2.5 ± 3.9 |
Angiographic data (n,%) | |
Single vessel | 71(43.3) |
Double vessels | 50(30.5) |
Triple vessels | 43(26.2) |
Main stem involved | 20(12) |
Multivessel | 93(57) |